Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
To evaluate of adjuvant therapy using oxaliplatin and gemcitabine (GEMOX regimen) versus
capecitabine alone chemotherapy in patients who underwent curative surgery for intrahepatic
cholangiocarcinoma (ICC) -- a randomized control study.